Discontinued — last reported Q4 '17
nVent Electric plc Indefinite-Lived Research and Development Assets decreased by 0.8% to $367.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.8%, from $370.50M to $367.60M. Over 5 years (FY 2020 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 6.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates aggressive investment in external innovation, while a decrease may signal project completion, commercialization, or impairment charges.
This represents the value of acquired in-process research and development (IPR&D) projects that have not yet reached com...
Common in pharmaceutical and medical device sectors where M&A is a primary driver of R&D pipelines.
indefinite_lived_rd_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $273.10M | $273.10M | $312.20M | $370.50M | $367.60M |
| QoQ Change | — | +0.0% | +14.3% | +18.7% | -0.8% |
| YoY Change | — | +0.0% | +14.3% | +18.7% | -0.8% |